Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug delivery pump warning

This article was originally published in Clinica

Executive Summary

Home use of a terbutaline-filled pump to prevent premature labour is dangerous, claims the US National Women's Health Network. The group has asked the FDA to forbid Matria Healthcare from renting the device or, at least, warn doctors of terbutaline's risks and lack of proven efficacy. The NWHN claims at least two women died using the pumps; another eight or more suffered heart or lung problems; and one baby was born with heart damage linked to the pump and drug.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088615

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel